1,457 results on '"Masliah, E"'
Search Results
302. Alterations in Apolipoprotein E Expression During Aging and Neurodegeneration
303. Severe alveolar proteinosis following chemotherapy for acute myeloid leukemia in a lung allograft recipient.
304. Subpial vacuolar myelopathy after intrathecal ketamine: report of a case.
305. Rapidly progressive dementia in a patient with the Lewy body variant of Alzheimer's disease.
306. Accumulation of oligomer-prone alpha-synuclein exacerbates synaptic and neuronal degeneration in vivo
307. The role of NAC in amyloidogenesis in Alzheimer's disease [2] (multiple letters)
308. Risk for cognitive impairment among HIV-infected persons with bipolar disorder
309. Absence of elevated anti-α-synuclein and anti-EBV latent membrane protein antibodies in PD
310. Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing
311. Kindling-induced changes of protein kinase C levels in hippocampus and neocortex
312. Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration
313. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice
314. MORPHOMETRIC QUANTIFICATION OF A SYNAPTIC MARKER IN NEOCORTEX OF ALZHEIMER AND PICK DISEASE
315. A unified hypothesis for the histogenesis of the soft tissue sarcomas of unknown origin
316. Alternative splicing patterns of CYP2Dgenes in human brain and neurodegenerative disorders
317. Transgenic model of HIV-induced brain damage: successful therapy and implications for AIDS dementia complex
318. Absence of elevated anti-alpha-synuclein and anti-EBV latent membrane protein antibodies in PD.
319. 2.212 AFFITOPE® BASED VACCINES: A NOVEL AND SAFE IMMUNOTHERAPEUTIC STRATEGY FOR PARKINSON'S DISEASE
320. Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathy.
321. Megacystis miicrocolon intestinal hypoperistalsis syndrome: bladder distension and pyelectasis in the fetus without anatomic ooutflow obstruction
322. Synaptic and neuritic alterations during the progression of Alzheimer's disease
323. Natural evolution of the neurodegenerative alterations in Alzheimer's disease
324. What causes neurofibrillary tangle formation in Alzheimer's disease?
325. Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease
326. Synaptotrophic effects of human amyloid protein precursors in the cortex of transgenic mice
327. Cytokine receptor alterations during HIV infection in the human central nervous system
328. Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies
329. Amyloid precursor protein is localized in growing neurites of neonatal rat brain
330. Selective Neuronal Vulnerability in HIV Encephalitis
331. A novel non-ataxic guinea pig strain with cerebrocortical and cerebellar abnormalities
332. Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease
333. Early start of progressive motor deficits in Line 61 α-synuclein transgenic mice.
334. Differential calcium alterations in animal models of neurodegenerative disease: Reversal by FK506.
335. Silencing of murine transthyretin and retinol binding protein genes has distinct and shared behavioral and neuropathologic effects.
336. Phospholipase D1 regulates autophagic flux and clearance of α-synuclein aggregates.
337. F-spondin gene transfer improves memory performance and reduces amyloid-β levels in mice
338. Protein analysis through Western blot of cells excised individually from human brain and muscle tissue
339. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy.
340. Impaired postnatal development of hippocampal dentate gyrus in Sp4 null mutant mice.
341. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder following lung transplantation is more commonly of host origin.
342. Alpha-1-antichymotrypsin polymorphism in the gene promoter region affects survival and synapsis loss in Alzheimer's disease.
343. α-1-ANTICHYMOTRYPSIN POLYMORPHISM IN THE GENE PROMOTER REGION AFFECTS SURVIVAL AND SYNAPSIS LOSS IN ALZHEIMER’S DISEASE
344. Neurotrophic and chemokine dysfunction of HIV infected human brain macrophages
345. Primary role for macrophages/microglia in mediating a delayed onset neuroinflammatory disease in GFAP-TNF-α transgenic mice
346. 59-1 - Neurocognitive disturbances in HIV, including HIV-assoclated dementia
347. Mutations in COQ2 in Familial and Sporadic Multiple-System Atrophy
348. Herpes virus in Alzheimer's disease: relation to progression of the disease
349. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease
350. 22 NPT002: a novel approach for targeting β-amyloid and tau aggregates in Alzheimer's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.